Dietary L-arginine supplementation increases the hepatic expression of AMP-activated protein kinase in rats.
Academic Article
Overview
Research
Identity
Additional Document Info
Other
View All
Overview
abstract
The goal of this study was to elucidate the molecular mechanisms responsible for the anti-obesity effect of L-arginine supplementation in diet-induced obese rats. Male Sprague-Dawley rats were fed either a low-fat or high-fat diet for 15weeks. Thereafter, lean or obese rats were pair-fed their same respective diets and received drinking water containing either 1.51% L-arginine-HCl or 2.55% L-alanine (isonitrogenous control) for 12weeks. Gene and protein expression of key enzymes in the metabolism of energy substrates were determined using real-time polymerase-chain reaction and western blotting techniques. The mRNA levels of hepatic fatty acid synthase and stearoyl-CoA desaturase were reduced (P<0.05) but those of hepatic AMP-activated protein kinase- (AMPK), peroxisome proliferator activator receptor coactivator-1, and carnitine palmitoyltransferase I (CPT-I), as well as skeletal muscle CPT-I were increased (P<0.05) by L-arginine treatment. The protein expression and activity of hepatic AMPK markedly increased (P<0.05) but the activity of hepatic acetyl-CoA carboxylase (ACC) decreased (P<0.05) in response to dietary L-arginine supplementation. Collectively, our results indicate that liver is the major target for the action of dietary L-arginine supplementation on reducing white-fat mass in diet-induced obese rats by inhibiting fatty acid synthesis and increasing fatty acid oxidation via the AMPK-ACC signaling pathway. Additionally, increased CPT-I expression in skeletal muscle may also contribute to the enhanced oxidation of long-chain fatty acids in L-arginine-supplemented rats.
